Medistim ASA (OSL:MEDI)

Market Cap	4.55B
Revenue (ttm)	662.18M
Net Income (ttm)	142.42M
Shares Out	18.28M
EPS (ttm)	7.79
PE Ratio	31.97
Forward PE	27.97
Dividend	6.00 (2.41%)
Ex-Dividend Date	May 9, 2025

Volume	7,290
Average Volume	6,929
Open	252.00
Previous Close	249.00
Day's Range	247.00 - 252.00
52-Week Range	142.00 - 292.00
Beta	1.15
RSI	45.33
Earnings Date	Feb 27, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 154
• Stock Exchange: Oslo Børs
• Ticker Symbol: MEDI

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.